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TBC is a specific world-wide infectious disease, compounded by increased 
migrations of people, the spread of HIV and the growth of MDR-TB, including 
extremely resistant strains. Precisely for the growth of MDR-TB resistant mycobacteria 
the work is focused on the preparation and development of other possible 
antituberculosis drugs (Pyrazine derivatives). Research into new medications lays 
emphasis on altering the effects of enzymes important for the vitality of mycobacteria. 
As part of my diploma thesis, pyrazine derivative modifications of clinical 
pyrazinamide medications were prepared. PZA is an important part of the short-term 
TBC treatment, having a sterile effect and the ability to work in an acidic environment 
and has a significant synergy with rifampicin. The small PZA molecule is a precursor to 
the pyrazine acid activated by pyrazinamide or nicotinamide. Hydrolysis of PZA in 
mycobacterial cells create Pyrazinecarboxylic acid (POA). 
 
 In the experimental part, we have examined the variation molecules 
pyrazinamide and preparing the new derivatives with potential antituberculotic activity. 
We have prepared several derivatives with aliphatic and aromatic substituents via 
oxygen bond.. Part of this work was also the prediction of new compounds (docking). 
Successfully prepared and confirmed agents will be in the next phase subsequently 
subjected to in-vitro testing. 
 
